Drug Manufacturing and Formulation Program (DMFP)

Award Notice Posted

Solicitation number
75N95024R00077
Agency
Awarded
Set-aside
No set-aside

Opportunity facts

Contract number
75N98026D00012-75N98026F00001
Place of performance
Alachua, Florida, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services awarded a 4-contract IDIQ suite for the Drug Manufacturing and Formulation Program (DMFP) on May 4, 2026, with a combined maximum ordering value of $49,999,999.00.

Each IDIQ carries a 10-year ordering period from May 4, 2026 through May 3, 2036. Concurrently with the IDIQ awards, the first task orders were issued to each awardee effective May 4, 2026 through July 3, 2026 in the firm-fixed price amount totaling $5,000.00 across all four contracts. ALCHEM LABORATORIES CORPORATION was awarded contract 75N98026D00012 for the full $49,999,999.00 maximum value. The award was made under no set-aside.

Notice text

Four (4) Indefinite Delivery/Indefinite Quantity (IDIQ) type contracts with a maximum ordering value of $49,999,999.00 and an ordering period from May 4, 2026 through May 3, 2036, were awarded on May 4, 2026. Concurrently, the first task orders were issued to each awardee with an effective date of May 4, 2026 through July 3, 2026, in the firm-fixed price amount totaling $5,000.00. 

Awarded contract 75N98026D00012 to ALCHEM LABORATORIES CORPORATION for 49999999.00 on 2026-05-04.

Notice history

Notice Type Posted
Drug Manufacturing and Formulation Program (DMFP) Latest Award Notice
Drug Manufacturing and Formulation Program (DMFP) Award Notice
Drug Manufacturing and Formulation Program (DMFP) Award Notice
This notice Award Notice
Drug Manufacturing and Formulation Program (DMFP) Latest solicitation Solicitation
Drug Manufacturing and Formulation Program (DMFP) Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
Synthesis and Distribution of Drugs of Abuse and Related Compounds NAICS 541715 National Institute on Drug Abuse No set-aside
Synthesis and Distribution of Drugs of Abuse and Related Compounds NAICS 541715 National Institute on Drug Abuse Total Small Business

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors